IMM 2.94% 33.0¢ immutep limited

Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 136 Posts.
    lightbulb Created with Sketch. 84
    I’m expecting new data, but everything I’m reading implies they released final results today? My name is on 2 abstracts released today at SITC, and I promise you never blow your load until conference. As in I expected the separate AIPAC OS press release day of presentation. The TACT-002 head and neck is also identical to ASCO last summer, best I can tell?
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
-0.010(2.94%)
Mkt cap ! $480.0M
Open High Low Value Volume
33.0¢ 33.5¢ 32.0¢ $1.703M 5.215M

Buyers (Bids)

No. Vol. Price($)
1 211685 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 279000 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.